PLA2G3 and colitis: To further assess the relationship between the ameliorating effect of sPLA2-III deficiency on colitis (Fig. 3) and that on colorectal cancer (Fig. 2), we next subjected Pla2g3−/− and control Pla2g3+/+ mice to chronic DSS treatment (Fig. 4a).